Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) receives EU MDR Class II Regulatory Approval
Bangalore (Karnataka) [India], February 23 (ANI/PRNewswire): Remidio has received CE mark approval for its Medios AI, to detect Referable DR
Source: webindia123.com